385 women with normal glucose tolerance in an oral glucose tolerance test (OGTT, 75 g glucose dose after overnight fasting) during pregnancy served as controls. Women with a diagnosis of type 1 ...
Sitagliptin (Januvia™) is a new oral agent approved by the US FDA to treat Type 2 diabetes. This is the first approved agent in a new class of antihyperglycemics, dipeptidyl peptidase (DPP)-4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results